331 related articles for article (PubMed ID: 16980203)
1. Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):421-34. PubMed ID: 16980203
[TBL] [Abstract][Full Text] [Related]
2. Phaeochromocytomas and functional paragangliomas: clinical management.
Plouin PF; Amar L; Lepoutre C
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
4. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
5. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors].
Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M
Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986
[TBL] [Abstract][Full Text] [Related]
6. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
[TBL] [Abstract][Full Text] [Related]
8. [Hereditary phaeochromocytoma in twins].
Tóth G; Patócs A; Tóth M
Orv Hetil; 2016 Aug; 157(33):1326-30. PubMed ID: 27523316
[TBL] [Abstract][Full Text] [Related]
9. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
[TBL] [Abstract][Full Text] [Related]
10. Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay.
Chew SL; Dacie JE; Reznek RH; Newbould EC; Sheaves R; Trainer PJ; Lowe DG; Shand WS; Hungerford J; Besser GM
Q J Med; 1994 Jan; 87(1):49-54. PubMed ID: 8140217
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice.
Zelinka T; Eisenhofer G; Pacak K
Stress; 2007 Jun; 10(2):195-203. PubMed ID: 17514588
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma: a review.
Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
[TBL] [Abstract][Full Text] [Related]
13. Phaeochromocytoma, new genes and screening strategies.
Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
[TBL] [Abstract][Full Text] [Related]
14. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
15. Phaeochromocytoma: state-of-the-art.
Donckier JE; Michel L
Acta Chir Belg; 2010; 110(2):140-8. PubMed ID: 20514823
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma: diagnostic and therapeutic update.
Oleaga A; Goñi F
Endocrinol Nutr; 2008 May; 55(5):202-16. PubMed ID: 22967914
[TBL] [Abstract][Full Text] [Related]
19. Familial paraganglioma syndromes.
Chetty R
J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
[TBL] [Abstract][Full Text] [Related]
20. [Genetic diagnosis of phaeochromocytomas and paragangliomas].
Cardot-Bauters C; Ainaouï M; Coppin L; Pigny P
Presse Med; 2014 Apr; 43(4 Pt 1):460-7. PubMed ID: 24612707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]